|
|
| | beta-Escin Basic information |
| Product Name: | beta-Escin | | Synonyms: | B-escin;beta-aescusan;BETA-ESCIN;BETA-AESCIN;Escin (beta-Escin);b-Aescin crystalline;Escin (350 mg);ESCIN IIB; AESCIN IIB | | CAS: | 11072-93-8 | | MF: | C55H86O24 | | MW: | 1131.26 | | EINECS: | 600-985-2 | | Product Categories: | | | Mol File: | 11072-93-8.mol |  |
| | beta-Escin Chemical Properties |
| Melting point | 222-223° | | alpha | D27 -23.7° (c = 5 in methanol) | | Boiling point | 764.81°C (rough estimate) | | density | 1.1200 (rough estimate) | | refractive index | 1.6500 (estimate) | | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | | solubility | DMF: 1 mg/ml,DMSO: 1 mg/ml | | form | powder | | color | white |
| Hazard Codes | Xn | | Risk Statements | 22 | | Safety Statements | 22-24/25 | | WGK Germany | 2 | | RTECS | KF6296000 | | HS Code | 2938900000 | | Toxicity | LD50 in mice, rats, guinea pigs (mg/kg): 1.4, 2.0, 7.2 i.v.; 134, 400, 188 orally (Hampel) |
| | beta-Escin Usage And Synthesis |
| Uses | Escin has been used as a treatment for ischemic damage, hemorrhoids, and trauma or for recovery post-operation. Also used in the treatment of adenocarcinoma cell lines. | | Uses | Peripheral vascular disorders |
| | beta-Escin Preparation Products And Raw materials |
|